ClassID:

21256

A61K45/06 - page 35 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  -  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Recent Application in this class:
#10201
20220296611
2022-09-22

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER

#10202
20220296610
2022-09-22

COMPOSITIONS AND METHODS FOR TREATMENT OF INFECTION AND NOVEL COSMECEUTICAL PREPARATIONS

#10203
20220296606
2022-09-22

NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU

#10204
20220296591
2022-09-22

ORGANIC COMPOUNDS

#10205
20220296588
2022-09-22

Pemafibrate dosing regimens

#10206
20220296583
2022-09-22

COMPOSITIONS AND METHODS FOR TREATMENT OF OVARIAN AND BREAST CANCER

#10207
20220296582
2022-09-22

METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME

#10208
20220296570
2022-09-22

USE OF AMISULPRIDE AS AN ANTI-EMETIC

#10209
20220296567
2022-09-22

Oral dissolvable film that includes plant extract

#10210
20220296562
2022-09-22

Nutraceutical compositions

#10211
20220296557
2022-09-22

COMBINATIONS OF BCL-2/BCL-XL INHIBITORS AND RELATED USES

#10212
20220296548
2022-09-22

PREVENTATIVE OR THERAPEUTIC AGENT FOR TAUOPATHY

#10213
20220296547
2022-09-22

METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES

#10214
20220296546
2022-09-22

Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators

#10215
20220296543
2022-09-22

METHODS AND COMPOSITIONS FOR PREVENTING SKIN TOXICITIES CAUSED BY BIOLOGICAL TARGETED CANCER DRUGS

#10216
20220296537
2022-09-22

NOVEL PHARMACEUTICAL COMPOSITIONS

#10217
20220296529
2022-09-22

PRE-FILLING SYSTEM TO ELIMINATE BUBBLES INSIDE CAPSULES HAVING A SOLID DOSAGE FORMS WITHIN SAID CAPSULES

#10218
20220296528
2022-09-22

Pharmaceutical compositions of berberine with EPA and DHA, and methods thereof

#10219
20220296500
2022-09-22

Method and System for Preventing Sore Throat in Humans

#10220
20220290241
2022-09-15

PREDICTING EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE

#10221
20220290179
2022-09-15

GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF USES THEREOF

#10222
20220290159
2022-09-15

miRNAS FOR REDUCING VENTRICLE ENLARGEMENT

#10223
20220289864
2022-09-15

PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS INJECTION COMPRISING HUMAN HYALURONIDASE PH20 VARIANT AND DRUG

#10224
20220289861
2022-09-15

Immunomodulatory antibodies and methods of use thereof

#10225
20220289837
2022-09-15

Cystic Fibrosis Transmembrane Conductance Regulator Stabilizing Agents

#10226
20220289836
2022-09-15

Anti-PACAP antibodies and uses thereof

#10227
20220289835
2022-09-15

SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL-23 SPECIFIC ANTIBODY

#10228
20220289831
2022-09-15

Use of beta-catenin as a biomarker for treating cancers using anti-Dkk-1 antibody

#10229
20220289829
2022-09-15

ANTI-HIV VACCINE ANTIBODIES WITH REDUCED POLYREACTIVITY

#10230
20220289828
2022-09-15

HUMAN MONOCLONAL ANTIBODIES TO ENTEROVIRUS D68

#10231
20220289827
2022-09-15

NEUTRALIZING ANTIBODIES TO SARS-COV-2 AND ITS VARIANTS

#10232
20220289809
2022-09-15

USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION

#10233
20220289802
2022-09-15

NEMO COILED COIL MIMICS AND METHODS OF USING SAME

#10234
20220289775
2022-09-15

ENPP1 Inhibitors and Methods of Modulating Immune Response

#10235
20220289736
2022-09-15

NLRP3 modulators

#10236
20220289734
2022-09-15

3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS

#10237
20220289730
2022-09-15

(R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASES

#10238
20220289721
2022-09-15

Compounds for the treatment of BRAF-associated diseases and disorders

#10239
20220289686
2022-09-15

COMPOSITIONS OF NRF2 INHIBITING AGENTS AND METHODS OF USE THEREOF

#10240
20220289663
2022-09-15

Metabolism resistant fenfluramine analogs and methods of using the same

#10241
20220288408
2022-09-15

System and methods for treating cancer cells with alternating polarity magnetic fields

#10242
20220288407
2022-09-15

System and methods for treating cancer cells with alternating polarity magnetic fields

#10243
20220288404
2022-09-15

METHODS FOR APPLYING TUMOR TREATING FIELDS IN COMBINATION WITH CANCER TREATING THERAPEUTICS

#10244
20220288395
2022-09-15

Methods of Treating Disease by Skewing Macrophage Phenotype with Alternating Electric Fields

#10245
20220288284
2022-09-15

Medical devices for continuous delivery of therapeutic agents

#10246
20220288227
2022-09-15

Ultrasound Responsive Microbubbles And Related Methods

#10247
20220288211
2022-09-15

DOSAGE-INDICATING TOPICAL FORMULATION AND METHOD OF USING A DOSAGE-INDICATING TOPICAL FORMULATION

#10248
20220288210
2022-09-15

Photosensitizing antibody-fluorophore conjugates

#10249
20220288205
2022-09-15

HOMEOPATHIC COMPLEX

#10250
20220288204
2022-09-15

DOSAGE AND ADMINISTRATION OF ANTI-ERBB3 (HER3) MONOCLONAL ANTIBODIES TO TREAT TUMORS ASSOCIATED WITH NEUREGULIN 1 (NRG1) GENE FUSIONS

#10251
20220288189
2022-09-15

INFLUENZA HEMAGGLUTININ PROTEINS AND METHODS OF USE THEREOF

#10252
20220288166
2022-09-15

MICROVASCULAR BLOOD FLOW DECREASING AGENT AND USE THEREOF

#10253
20220288163
2022-09-15

CYTOKINE MODULATION

#10254
20220288158
2022-09-15

NOVEL ENTERIC COMBINATION THERAPY

#10255
20220288143
2022-09-15

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING VACCINIA VIRUS AND GRANULOPOIESIS INHIBITOR AS ACTIVE INGREDIENTS

#10256
20220288141
2022-09-15

GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS

#10257
20220288126
2022-09-15

Alkalized organic pharmaceutical or nutraceutical composition

#10258
20220288118
2022-09-15

DEPLETION REGIMES FOR ENGINEERED T-CELL OR NK-CELL THERAPY

#10259
20220288102
2022-09-15

Compounds for Hepatitis B Treatment

#10260
20220288099
2022-09-15

Synergistic formulations of adenosine receptor modulating agents and anticholinergics

#10261
20220288091
2022-09-15

Method for Improving Insulin Sensitivity

#10262
20220288086
2022-09-15

TREATMENT FOR BACTERIAL INFECTION

#10263
20220288083
2022-09-15

D9-caffeine compositions and uses thereof

#10264
20220288080
2022-09-15

Method against severe acute respiratory syndrome coronavirus 2 infection

#10265
20220288079
2022-09-15

Small molecule trail gene induction by normal and tumor cells as an anticancer therapy

#10266
20220288077
2022-09-15

PROSTATITIS TREATMENT

#10267
20220288074
2022-09-15

Compounds for the treatment of BRAF-associated diseases and disorders

#10268
20220288072
2022-09-15

Optically active azabicyclo ring derivative

#10269
20220288069
2022-09-15

INHIBITORS OF TYROSINE KINASE

#10270
20220288068
2022-09-15

PHARMACEUTICAL PREPARATION

#10271
20220288065
2022-09-15

MONOCYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING

#10272
20220288062
2022-09-15

TREATMENT OF T-CELL MEDIATED DISEASES

#10273
20220288060
2022-09-15

Treatment of Opioid Withdrawal

#10274
20220288055
2022-09-15

CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF PREPARATION THEREOF

#10275
20220288054
2022-09-15

COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

#10276
20220288051
2022-09-15

METHODS FOR TREATING CANCER USING SERIAL ADMINISTRATION OF E3 UBIQUITIN LIGASE DEGRADERS

#10277
20220288047
2022-09-15

METHOD FOR TREATING A DISEASE OR CONDITION USING A PYRAZOLE COMPOUND OR FORMULATION THEREOF

#10278
20220288041
2022-09-15

SMALL MOLECULE INHIBITOR OF THE JAK FAMILY OF KINASES

#10279
20220288040
2022-09-15

USE OF PYRVINIUM FOR THE TREATMENT OF A RAS PATHWAY MUTATED ACUTE MYELOID LEUKEMIA

#10280
20220288034
2022-09-15

METHOD OF REDUCING ABERRANT IMMUNE RESPONSE OR RISK OF PROGRESSION IN COVID-19

#10281
20220288030
2022-09-15

GLP-1R modulating compounds

#10282
20220288028
2022-09-15

A THERAPEUTIC APPROACH FOR TREATING NON-INFECTIOUS OCULAR IMMUNOINFLAMMATORY DISORDERS

#10283
20220288027
2022-09-15

Methods of improving renal function

#10284
20220288026
2022-09-15

METHODS OF TREATING KIDNEY DISEASES

#10285
20220288019
2022-09-15

Methods of treating cancer using a combination of SERD Dosing Regimens

#10286
20220288018
2022-09-15

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PRE-DIABETES, DIABETES AND METABOLIC SYNDROME

#10287
20220288015
2022-09-15

CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF

#10288
20220288012
2022-09-15

Pharmaceutical composition, methods for treating and uses thereof

#10289
20220288010
2022-09-15

METHODS FOR REDUCING REWARDING EFFECTS OF MORPHINE WITHOUT AFFECTING ITS ANALGESIC EFFECTS

#10290
20220288003
2022-09-15

COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY

#10291
20220287994
2022-09-15

N,N-bis-2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseases

#10292
20220287986
2022-09-15

Intraarterial (IA) Application of Low Dose of Ethyl Alcohol Enables Blood-Brain Barrier (BBB) Impermeable Therapeutics Brain Entry

#10293
20220287980
2022-09-15

PHARMACEUTICAL COMPOSITION AND USES THEREOF

#10294
20220287977
2022-09-15

ORAL PRODUCTS AND METHODS OF MANUFACTURE

#10295
20220287965
2022-09-15

OLEOGELS AND METHODS RELATING THERETO

#10296
20220287962
2022-09-15

Devices and methods for treating ear pain

#10297
20220287947
2022-09-15

HYDROGEL BASED ON ZINC GLUCONATE AND HYALURONIC ACID ESTERS

#10298
20220287937
2022-09-15

SKIN SERUM AND PROCESS OF MAKING THE SAME

#10299
20220282254
2022-09-08

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD

#10300
20220282216
2022-09-08

Primary NK CAR Constructs And Methods

#10301
20220281993
2022-09-08

Method and Compositions for Inducing Differentiation of Myeloid Derived Suppressor Cell to Treat Cancer and Infectious Diseases

#10302
20220281979
2022-09-08

Anti-PD-1 antibodies for treatment of lung cancer

#10303
20220281970
2022-09-08

Pharmaceutical Combinations

#10304
20220281968
2022-09-08

Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

#10305
20220281930
2022-09-08

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH

#10306
20220281929
2022-09-08

Method for the treatment of a relapsing-remitting condition

#10307
20220281919
2022-09-08

pH-SENSITIVE CYCLIC PEPTIDES

#10308
20220281917
2022-09-08

Immunotherapy against several tumors including lung cancer

#10309
20220281893
2022-09-08

TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF

#10310
20220281886
2022-09-08

NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES

#10311
20220281878
2022-09-08

1H-[1, 2, 3]triazolo[4, 5-h] quinazoline compounds acting as protein kinase inhibitors

#10312
20220281871
2022-09-08

Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK Inhibitors

#10313
20220281863
2022-09-08

COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS

#10314
20220281857
2022-09-08

Prodrug Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use

#10315
20220281854
2022-09-08

COMBINATION THERAPY FOR TREATING CANCER

#10316
20220281839
2022-09-08

Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands

#10317
20220281828
2022-09-08

AURORA KINASE AND JANUS KINASE INHIBITORS FOR PREVENTION OF GRAFT VERSUS HOST DISEASE

#10318
20220281825
2022-09-08

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION

#10319
20220281815
2022-09-08

CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS

#10320
20220280663
2022-09-08

CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM

#10321
20220280641
2022-09-08

METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY

#10322
20220280640
2022-09-08

FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE

#10323
20220280624
2022-09-08

VACCINE COMPOSITIONS COMPRISING C-C MOTIF CHEMOKINE 22 (CCL22) OR FRAGMENTS THEREOF

#10324
20220280609
2022-09-08

COMBINATION CANCER THERAPY AGENTS AND METHODS

#10325
20220280607
2022-09-08

Treatment of Heart Defects and Conditions in Pediatric Patients

#10326
20220280606
2022-09-08

METHOD OF PREPARING A DE-FIBRINATED PLATELET LYSATE, AND USES OF SAID METHOD

#10327
20220280601
2022-09-08

METHOD FOR TREATMENT OF HEPATIC CANCER USING REIC/Dkk-3 GENE IN COMBINATION WITH ANTI-TUMOR AGENT

#10328
20220280592
2022-09-08

Collagen peptide-based medicament compositions and devices and methods of production and use thereof

#10329
20220280577
2022-09-08

Engineered immunostimulatory bacterial strains and uses thereof

#10330
20220280573
2022-09-08

HUMAN UMBILICAL CORD-DERIVED COMPOSITIONS AND USES THEREOF FOR TREATING NEUROPATHY

#10331
20220280534
2022-09-08

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

#10332
20220280533
2022-09-08

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

#10333
20220280526
2022-09-08

AGENT FOR THE TREATMENT OF PSORIASIS

#10334
20220280525
2022-09-08

RAC INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR EGFR/HER2 TARGETED THERAPY RESISTANT BREAST CANCER

#10335
20220280523
2022-09-08

COMBINATION OF PI3K INHIBITOR AND C-MET INHIBITOR

#10336
20220280519
2022-09-08

COMBINATIONS OF AGENTS TO TREAT HEMATOLOGICAL MALIGNANCIES

#10337
20220280511
2022-09-08

CDK4/6 INHIBITORS FOR THE TREATMENT OF PSORIASIS

#10338
20220280509
2022-09-08

AZA-QUINOLINE COMPOUNDS AND USES THEREOF

#10339
20220280498
2022-09-08

Dizocilpine derivatives as peripheral NMDA receptor antagonists

#10340
20220280494
2022-09-08

COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS

#10341
20220280485
2022-09-08

Hodgkin lymphoma therapy

#10342
20220280479
2022-09-08

SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES

#10343
20220280477
2022-09-08

Compositions And Methods For Treating Traumatic Brain Injury

#10344
20220280467
2022-09-08

Methods and compositions for treating infection and inflammation with selenocyanate

#10345
20220280466
2022-09-08

Memory in subjects with mini-mental state examination of 24-26

#10346
20220280452
2022-09-08

METHODS AND COMPOSITIONS FOR TREATING SMITH-MAGENIS SYNDROME

#10347
20220280451
2022-09-08

TREATMENT OF COPPER DISORDER

#10348
20220280450
2022-09-08

PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED RESPIRATORY INFECTIONS

#10349
20220280434
2022-09-08

RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS

#10350
20220280430
2022-09-08

Treprostinil derivatives and their use in pharmaceutical compositions

#10351
20220280429
2022-09-08

Tunable leukocyte-based biomimetic nanoparticles and methods of use

#10352
20220280428
2022-09-08

TUNABLE LEUKOCYTE-BASED BIOMIMETIC NANOPARTICLES AND METHODS OF USE

#10353
20220280233
2022-09-08

DEVICES, METHODS, AND COMPOSITIONS FOR THERMAL ACCELERATION AND DRUG DELIVERY

#10354
20220279793
2022-09-08

Stable compositions of uncomplexed iodine and methods of use

#10355
20220276173
2022-09-01

Application of raman spectroscopy for the manufacture of inhalation powders

#10356
20220275399
2022-09-01

Adeno-associated virus virions for treatment of epilepsy

#10357
20220275371
2022-09-01

USE OF RAB7 GTPASE (RAB7) INHIBITORS IN ENHANCING PERMEABILITY OF THE BLOOD BRAIN BARRIER (BBB)

#10358
20220275368
2022-09-01

NEW TREATMENTS INVOLVING MIRNA-193A

#10359
20220275102
2022-09-01

ANTI-CD38 ANTIBODIES AND METHODS OF USE

#10360
20220275101
2022-09-01

Use of Approved Anti-CD38 Antibody Drug Product to Treat Light Chain Amyloidosis

#10361
20220275094
2022-09-01

Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases

#10362
20220275084
2022-09-01

Antifibrotic activity of CD47 blockade in the liver

#10363
20220275072
2022-09-01

ANTIBODIES THAT BIND TO PATHOLOGICAL TAU SPECIES AND USES THEREOF

#10364
20220275049
2022-09-01

ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF

#10365
20220275042
2022-09-01

RELAXIN ANALOGS AND METHODS OF USING THE SAME

#10366
20220275035
2022-09-01

FCRN ANTAGONISTS AND METHODS OF USE

#10367
20220275032
2022-09-01

HSP Fusion Protein with Anti-Chemorepellant Agent for Treatment of Cancer

#10368
20220275017
2022-09-01

Minimal saponin analogues, synthesis and use thereof

#10369
20220274996
2022-09-01

Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment

#10370
20220274991
2022-09-01

SMALL MOLECULE INHIBITORS OF KU70/80 AND USES THEREOF

#10371
20220274987
2022-09-01

PYRAZINO [1,2-B]QUINAZOLINE-3,6-DIONES DERIVATIVES, THEIR PRODUCTION AND USES THEREOF

#10372
20220274977
2022-09-01

NOVEL INHIBITORS

#10373
20220274974
2022-09-01

Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer

#10374
20220274972
2022-09-01

CLASS OF TRIAROMATIC COMPOUNDS TARGETING BIFUNCTIONAL PHOSPHORYLATION SITE OF STAT3 AND APPLICATIONS THEREOF

#10375
20220274964
2022-09-01

5-BROMO-INDIRUBINS

#10376
20220274962
2022-09-01

Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof

#10377
20220274955
2022-09-01

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

#10378
20220274951
2022-09-01

METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA

#10379
20220274948
2022-09-01

SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN

#10380
20220274926
2022-09-01

Immunoregulatory agents

#10381
20220274910
2022-09-01

Method of treating ocular disorders with compounds found in Harderian gland secretions

#10382
20220273815
2022-09-01

ENHANCED TRANSDUCTION OF AAV VECTORS ENCODING MICRORNAS

#10383
20220273805
2022-09-01

Cannabinoid Conjugate Molecules

#10384
20220273801
2022-09-01

COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION

#10385
20220273800
2022-09-01

Vaginal hydrogel

#10386
20220273799
2022-09-01

Drug delivery composition, method forming the same and method for treating inner ear disorders

#10387
20220273797
2022-09-01

Homeopathic complex

#10388
20220273780
2022-09-01

SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER

#10389
20220273760
2022-09-01

A TEIXOBACTIN ANALOGUE AND USE THEREOF

#10390
20220273753
2022-09-01

Peptidomimetics for the treatment of coronavirus and picorna virus infections

#10391
20220273746
2022-09-01

COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF ATOPIC DERMATITIS DISEASE

#10392
20220273743
2022-09-01

COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF RESPIRATORY DISEASE

#10393
20220273736
2022-09-01

METHODS OF DETECTING OVARIAN CANCER

#10394
20220273733
2022-09-01

NUTRITIVE COMPOSITIONS WITH BIOACTIVE PROTEINS

#10395
20220273731
2022-09-01

COMPOSITIONS AND METHODS OF TREATMENT OF CHRONIC INFECTIOUS DISEASES

#10396
20220273703
2022-09-01

NRF2 ACTIVATION FOR TREATMENT OF NEPHROGENIC DIABETES INSIPIDUS

#10397
20220273696
2022-09-01

Altering microbial populations and modifying microbiota

#10398
20220273694
2022-09-01

COMPOSITIONS AND METHODS FOR DECREASING INTRAOCULAR PRESSURE

#10399
20220273688
2022-09-01

Treatment of Glycosylation Deficiency Diseases

#10400
20220273683
2022-09-01

BORON-CONTAINING SMALL MOLECULES

#10401
20220273671
2022-09-01

TOPICAL FORMULATIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES

#10402
20220273667
2022-09-01

PI3K INHIBITOR FOR USE IN THE THERAPY OF B CELL LYMPHOMA

#10403
20220273644
2022-09-01

Compounds for use in a method of treating or preventing neurological and/or psychiatric disorders

#10404
20220273637
2022-09-01

NOVEL PFAR-INHIBITING COMPOUNDS

#10405
20220273636
2022-09-01

Compounds for use in treating depression and migraine

#10406
20220273628
2022-09-01

EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND OF LSD ANALOGS TO ASSIST PSYCHOTHERAPY FOR GENERALIZED ANXIETY DISORDER OR OTHER ANXIETY NOT RELATED TO LIFE-THREATENING ILLNESS

#10407
20220273626
2022-09-01

Therapeutic use of levorotatory β-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels

#10408
20220273613
2022-09-01

Composition containing artesunate

#10409
20220273610
2022-09-01

ANTIMYCOTIC

#10410
20220273607
2022-09-01

METHODS OF USING MODIFIED CYTOTOXINS TO TREAT CANCER

#10411
20220273604
2022-09-01

COMPOSITIONS AND METHODS FOR STIMULATING VENTILATORY AND/OR RESPIRATORY DRIVE

#10412
20220273600
2022-09-01

LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF

#10413
20220273595
2022-09-01

COMPOSITIONS AND METHODS FOR TREATING ECZEMA

#10414
20220273592
2022-09-01

ANALGESIC FORMULATION FOR PERINEAL PAIN

#10415
20220273589
2022-09-01

Diagnosis and Treatment of Vitiligo

#10416
20220273588
2022-09-01

MONOAMINE OXIDASE B INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF PROSTATE CARCINOMA

#10417
20220273587
2022-09-01

ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS

#10418
20220273585
2022-09-01

Composition comprising at least one natural or synthetic non-euphoric cannabinoid and its method of manufacture

#10419
20220273584
2022-09-01

Film Formulation Comprising Carriers

#10420
20220273582
2022-09-01

CONTINUOUS METHOD FOR NANO-EMULSIFICATION BY CONCENTRATION PHASE INVERSION

#10421
20220273564
2022-09-01

Treatment of hip pain with sustained-release liposomal anesthetic compositions

#10422
20220273563
2022-09-01

Vaccine adjuvant formulation

#10423
20220270709
2022-08-25

High-Throughput Identification of Patient-Specific Neoepitopes as Therapeutic Targets for Cancer Immunotherapies

#10424
20220270454
2022-08-25

TREATMENT OF KIDNEY DISEASES ASSOCIATED WITH ELEVATED AVP

#10425
20220267864
2022-08-25

THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER

#10426
20220267801
2022-08-25

ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS

#10427
20220267797
2022-08-25

Modified AAV Capsid Proteins for Treatment of Arthritic Disease

#10428
20220267775
2022-08-25

CANCER TREATMENT USING TARGETED siRNA PHARMACEUTICAL FORMULATIONS TO DOWNREGULATE EXPRESSION OF PRDM14 PROTEIN

#10429
20220267772
2022-08-25

IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME

#10430
20220267471
2022-08-25

Human Anti-SOD1 Antibodies

#10431
20220267455
2022-08-25

ANTI-IL1RAP ANTIBODIES AND ANTIBODY DRUG CONJUGATES

#10432
20220267442
2022-08-25

METHODS AND COMPOSITIONS FOR TARGETING TGF-ß SIGNALING IN CD4+ HELPER T CELLS FOR CANCER IMMUNOTHERAPY

#10433
20220267430
2022-08-25

Compositions and methods for treatment of diseases involving CXCL1 function

#10434
20220267429
2022-08-25

Use of TGF-alpha polypeptide or anti-TGF-alpha antibodies for the treatment of diseases and disorders

#10435
20220267418
2022-08-25

ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF

#10436
20220267402
2022-08-25

LONG-LASTING GLP1 ANALOGUE DRUG FOR TYPE-2 DIABETES

#10437
20220267390
2022-08-25

MPS MODIFIED PEPTIDES AND USE THEREOF

#10438
20220267377
2022-08-25

COMPOSITIONS COMPRISING CHEMERIN ANALOGS AND METHODS OF USE

#10439
20220267376
2022-08-25

P53 ACTIVATOR PEPTIDOMIMETIC MACROCYCLES

#10440
20220267332
2022-08-25

SUBSTITUTED FUSED HETEROAROMATIC BICYCLIC COMPOUNDS AS KINASE INHIBITORS AND THE USE THEREOF

#10441
20220267329
2022-08-25

Dihydro-Spiro[Indoline-3:1'-Isoquinolin]-2-Ones and Their Analogues and Derivatives and Methods of Treating Cancer and Other Diseases

#10442
20220267320
2022-08-25

4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES

#10443
20220267317
2022-08-25

Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2

#10444
20220267313
2022-08-25

DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES

#10445
20220267286
2022-08-25

2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof

#10446
20220267283
2022-08-25

HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE

#10447
20220267276
2022-08-25

NLRP MODULATORS

#10448
20220267275
2022-08-25

Inhibitors of influenza viral entry

#10449
20220267274
2022-08-25

TARGETING PTPN22 IN CANCER THERAPY

#10450
20220267268
2022-08-25

NEW TRICYCLIC 5-HT2 ANTAGONISTS

#10451
20220265850
2022-08-25

ANTIMICROBIAL NANO-DELIVERANT AND METHODS

#10452
20220265849
2022-08-25

Drug delivery vehicle, drug delivery system and methods thereof

#10453
20220265847
2022-08-25

METHODS AND COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER

#10454
20220265830
2022-08-25

LONG-ACTING FORMULATIONS AND VEHICLES

#10455
20220265821
2022-08-25

COMPOSITION AND METHODS OF TARGETING THE PRE-B CELL RECEPTOR FOR THE TREATMENT OF LEUKEMIAS AND LYMPHOMAS

#10456
20220265776
2022-08-25

COMBINATION

#10457
20220265758
2022-08-25

Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers

#10458
20220265750
2022-08-25

Composition for treatment of topical dermatological bacterial skin conditions

#10459
20220265747
2022-08-25

Compositions, Methods, and Medical Compositions for Treatment of and Maintaining the Health of the Liver

#10460
20220265726
2022-08-25

USE OF VETO CELLS FOR THE TREATMENT OF SICKLE CELL DISEASE

#10461
20220265720
2022-08-25

METHODS FOR STEM CELL TRANSPLANTATION

#10462
20220265719
2022-08-25

IMMUNOTHERAPIES

#10463
20220265718
2022-08-25

IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS

#10464
20220265716
2022-08-25

ANTIBODY PRE-LOADED CD16+NK-92 CELLS AS AN EFFECTIVE THERAPEUTIC PRODUCT FOR TUMOR LYSIS

#10465
20220265703
2022-08-25

Substituted phenyl boronic acid containing polymers and methods of use

#10466
20220265694
2022-08-25

COMPOSITIONS AND METHODS FOR TREATING AN INFECTION

#10467
20220265685
2022-08-25

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

#10468
20220265681
2022-08-25

Abiraterone prodrugs

#10469
20220265677
2022-08-25

Compositions and methods for preventing or treating muscle conditions

#10470
20220265674
2022-08-25

Parenteral compositions comprising methylene blue

#10471
20220265665
2022-08-25

Triazine formulations with a second active ingredient and surfactant(s)

#10472
20220265663
2022-08-25

Composition for treatment of muscular disorders

#10473
20220265656
2022-08-25

COMBINATION THERAPIES WITH IRE1 SMALL MOLECULE INHIBITORS

#10474
20220265655
2022-08-25

METHODS OF TREATING INFLAMMATORY DISEASES

#10475
20220265654
2022-08-25

DOSAGE REGIMENS FOR PARP7 INHIBITORS

#10476
20220265649
2022-08-25

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

#10477
20220265645
2022-08-25

Pyrazine-containing compound

#10478
20220265637
2022-08-25

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS

#10479
20220265629
2022-08-25

TREATMENT OF SYSTOLIC DYSFUNCTION AND HEART FAILURE WITH REDUCED EJECTION FRACTION WITH THE COMPOUND (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE

#10480
20220265628
2022-08-25

TREATMENT OF UROTHELIAL AND KIDNEY CANCERS BY USE OF ENDOTHELIN B RECEPTOR ANTAGONISTS

#10481
20220265617
2022-08-25

BET INHIBITORS AS A TREATMENT FOR MYELOFIBROSIS

#10482
20220265616
2022-08-25

REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS

#10483
20220265614
2022-08-25

TREATMENT COMPRISING FXR AGONISTS

#10484
20220265608
2022-08-25

Autotaxin inhibitor compounds

#10485
20220265604
2022-08-25

Treatment of mitochondrial diseases

#10486
20220265602
2022-08-25

COMBINATION OF A CHROMENE COMPOUND AND A SECOND ACTIVE AGENT

#10487
20220265592
2022-08-25

USE OF BIPOLAR TRANS CAROTENOIDS WITH CHEMOTHERAPY AND RADIOTHERAPY FOR TREATMENT OF CANCER

#10488
20220265590
2022-08-25

DIBENZYLAMINES AS AMINO ACID TRANSPORT INHIBITORS

#10489
20220265587
2022-08-25

Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases

#10490
20220265584
2022-08-25

Combination Therapies for Managing Cancer

#10491
20220265574
2022-08-25

METHODS OF USING CANNABIDIOL AND A STEROID

#10492
20220265568
2022-08-25

PROCESS FOR PREPARING PRESSURE SENSITIVE ADHESIVE COMPOUNDS FOR USE IN A TRANSDERMAL THERAPEUTIC SYSTEM

#10493
20220265551
2022-08-25

FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES

#10494
20220265487
2022-08-25

Absorbent structure for absorbent articles

#10495
20220264910
2022-08-25

COMPOSITIONS COMPRISING AMINO ACIDS AND A FURTHER COMPONENT FOR THE SUPPLY OF AMINO ACIDS TO A MONOGASTRIC ANIMAL SUCH AS A HUMAN OR A PIG

#10496
20220260590
2022-08-18

METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES

#10497
20220259673
2022-08-18

METHODS FOR IDENTIFYING AND TREATING HIGH-PLASTICITY CELL STATE DRIVING TUMOR PROGRESSION IN LUNG CANCER

#10498
20220259619
2022-08-18

COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY

#10499
20220259602
2022-08-18

INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION

#10500
20220259591
2022-08-18

Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)